PhD Ceremony: mw. M.K. Bakker, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy
Promotor(s): prof.dr. C.H.C.M. Buys, prof.dr. L.T.W. de Jong-Van den Berg
Faculty: Medical Sciences
Contact: via theUMCG, tel. 050-361 2200, e-mail:
We investigated, amongst others, possible risks associated with the use of selective serotonin reuptake inhibitors (SSRIs), which are currently the most prescribed drugs for depression and depressive symptoms. In the recent literature, use of SSRIs has been associated with an increased risk of congenital (heart) anomalies and other adverse pregnancy outcomes. In the Netherlands the use of SSRIs in pregnancy increased from 12 per 1000 pregnancies in 1995/1996 to 28 per 1000 pregnancies in 2003/2004. In a case-control study using data from Eurocat Northern Netherlands we found an increased risk for atrial septum defects after the use of paroxetine, a specific SSRI, in the first trimester of pregnancy. We also found a possible signal concerning the use of fluoxetine, another specific SSRI, and the occurrence of hypertrophic pylorus stenosis.
Hoe kunnen we op een efficiënte manier bioplastic maken uit suiker, zodat de prijs vergelijkbaar wordt met die van plastic uit aardolie? Daar doen de Rijksuniversiteit Groningen (RUG) en verschillende bedrijven en kennisinstellingen de komende drie...
The University of Groningen established the Ben Feringa Impact Award to highlight the exceptional achievements of researchers and students in the field of knowledge utilization.
The Northern Netherlands region is setting up the AI Hub Northern Netherlands, a new network organization that is bringing together companies, knowledge institutions and other organizations that work with artificial intelligence (AI).